ArticleCancer control : journal of the Moffitt Cancer Center

Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada.

Ashley Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.